Ordaos Bio
Manhattan
About Ordaos Bio
Orda┼ìs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Orda┼ìs, we help birth novel therapies that reduce patient suffering, improve health, and extend life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.8M
- Last round: Series Unknown (Apr 2025)
- Website: ordaos.bio
- Phone: 2016965358
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/ordaos-bio-119640 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.